Washington state’s top court has agreed to review a decision by a state appeals court that had handed Bayer’s Monsanto unit a legal victory in May in a case over allegations of chemical contamination at a school, The Wall Street Journal’s Adria Calatayud reports. The ruling had overturned an initial verdict that ordered Monsanto to pay $185M to plaintiffs who alleged they suffered injuries due to exposure to polychlorinated biphenyls. The Washington Supreme Court also accepted review of a cross-petition filed by the company on whether punitive damages should have been awarded, a company spokesman said. Monsanto said trial court errors identified in the May decision of the Court of Appeals are well reasoned and that there is no basis for a different outcome on appeal.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BAYRY:
- AstraZeneca, CSPC deal shows Lp(a) space remains hot, says BMO Capital
- Trinity Biotech provides update on CGM technology collaboration with Bayer
- Freight Technologies secures win with Bayer
- A Promising Pipeline Ready to Break out at BridgeBio Pharma (BBIO)
- BridgeBio presented additional data from an analysis of acoramidis studies